Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
ncarol.com/10213312

RESEARCH TRIANGLE PARK, N.C. - ncarol.com -- Elixia proudly welcomes Sam Searcy as the company's Chief Commercial Officer. Searcy will oversee activities related to marketing, enhance service offerings, expand Elixia's national site network, maintain client customer service, strategize Elixia's business growth, and increase Elixia's overall market share. Searcy will also manage Elixia's RTP office and the N.C.-based operations team.

"I am thrilled to have the opportunity to work with such a talented team. Elixia is truly implementing a breakthrough approach to clinical trials" Sam Searcy, CCO Searcy joins Elixia as an influential business and community leader with over 10 years of executive leadership roles in small and medium-sized companies in the life science sector. Searcy has a proven track record of building strong, efficient, and productive executive teams, and launching industry-disrupting products and services. Searcy also focuses on community as he serves on a number of corporate and volunteer Boards, including the N.C. Community College System, Appalachian State University Board of Visitors and ICE Global Consulting. He also serves as a Senior Advisor to NeuroVice, a Triangle-based medical device company focused on the medical needs of patients with various seizure disorders.

More on ncarol.com

• RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
• Claude Zdanow named Managing Director in Miami, Florida
• Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
• netElastic Announces vBNG And CGNAT 2.0 General Availability
• Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months

"We are excited to have Sam join the Elixia team. Sam's years of experience in life sciences will help Elixia navigate our current period of rapid growth." Neal Patel, CEO. The addition of Searcy will add value to the Elixia team, accelerate the company's goals, and support Elixia's overall mission.

About Elixia

Elixia is a tech-enabled clinical site organization specializing in Cardiology, Nephrology, Behavioral Health, and Infectious disease trials. Elixia's mission: To provide pharmaceutical companies with a breakthrough approach to clinical trials while empowering physician research, reinventing access to diverse populations, and accelerating the collection of data vital to high-quality clinical research outcomes while comprehensively supporting the drug development process. Elixia maintains corporate headquarters in Palm Beach FL, and the Research Triangle Park.